Search research articles
Contact Us
Filters
Showing results (161-170 of 282) with videos related to
Page
of 29
Sort By:
Oncoimmunology
|
June 5, 2013
Human perforin mutations and susceptibility to multiple primary cancers
Joseph A Trapani, Kevin Y T Thia, Miles Andrews, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2009
Melan-A-specific cytotoxic T cells are associated with tumor regression and autoimmunity following treatment with anti-CTLA-4
Oliver Klein, Lisa M Ebert, Theo Nicholaou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2009
Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma
Thomas E Hutson, Ian D Davis, Jean-Pascal H Machiels, et al.
Asia Oceania Journal of Nuclear Medicine & Biology
|
July 14, 2016
In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET
Peter K Wong, Sze Ting Lee, Carmel Murone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2009
Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma
Theo Nicholaou, Lisa M Ebert, Ian D Davis, et al.
The Medical Journal of Australia
|
June 4, 2013
Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011
Sue M Evans, Jeremy L Millar, Ian D Davis, et al.
BMC Cancer
|
August 31, 2018
Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours
Nicola J Lawrence, Howard Chan, Guy Toner, et al.
BJU International
|
March 8, 2021
UpFrontPSMA: a randomized phase 2 study of sequential <sup>177</sup> Lu-PSMA-617 and docetaxel vs docetaxel in metastatic hormone-naïve prostate cancer (clinical trial protocol)
Nattakorn Dhiantravan, Louise Emmett, Anthony M Joshua, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 17, 2013
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update
Cora N Sternberg, Robert E Hawkins, John Wagstaff, et al.
Cancer Immunity
|
February 23, 2005
Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma
Andrew M Scott, Zhanqi Liu, Carmel Murone, et al.
Page
of 29
Search research articles
Search
Showing results (161-170 of 282) with videos related to
Sort By:
Page
of 29
Oncoimmunology
|
June 5, 2013
Human perforin mutations and susceptibility to multiple primary cancers
Joseph A Trapani, Kevin Y T Thia, Miles Andrews, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2009
Melan-A-specific cytotoxic T cells are associated with tumor regression and autoimmunity following treatment with anti-CTLA-4
Oliver Klein, Lisa M Ebert, Theo Nicholaou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2009
Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma
Thomas E Hutson, Ian D Davis, Jean-Pascal H Machiels, et al.
Asia Oceania Journal of Nuclear Medicine & Biology
|
July 14, 2016
In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET
Peter K Wong, Sze Ting Lee, Carmel Murone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2009
Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma
Theo Nicholaou, Lisa M Ebert, Ian D Davis, et al.
The Medical Journal of Australia
|
June 4, 2013
Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011
Sue M Evans, Jeremy L Millar, Ian D Davis, et al.
BMC Cancer
|
August 31, 2018
Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours
Nicola J Lawrence, Howard Chan, Guy Toner, et al.
BJU International
|
March 8, 2021
UpFrontPSMA: a randomized phase 2 study of sequential <sup>177</sup> Lu-PSMA-617 and docetaxel vs docetaxel in metastatic hormone-naïve prostate cancer (clinical trial protocol)
Nattakorn Dhiantravan, Louise Emmett, Anthony M Joshua, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 17, 2013
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update
Cora N Sternberg, Robert E Hawkins, John Wagstaff, et al.
Cancer Immunity
|
February 23, 2005
Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma
Andrew M Scott, Zhanqi Liu, Carmel Murone, et al.
Page
of 29